THU0240

RAPID REDUCTIONS IN FATIGUE AND SLEEP PROBLEMS AND CORRELATION WITH IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES IN PATIENTS WITH ACTIVE RA TREATED WITH CERTOLIZUMAB PEGOL IN THE REALISTIC 12-WEEK PHASE IIIB RANDOMISED CONTROLLED STUDY

J. Pope 1,*R. Fleischmann 2M. Dougados 3C. O. Bingham 4E. Massarotti 5J. Wollenhaupt 6B. Duncan 7G. Coteur 8M. Weinblatt 5

1ST. JOSEPH'S HEALTH CARE, London, Canada, 2MCRC, Univ of Texas, Dallas, United States, 3Rene Descartes Univ, Paris, France, 4Johns Hopkins University, Baltimore, 5Brigham & Women’s Hospital, Boston, United States, 6Klinikum Eilbek, Hamburg, Germany, 7UCB, Raleigh, United States, 8UCB, Brussels, Belgium